Process Improvements. The parties acknowledge that CPL may develop improvements to the manufacturing process or procedure in the course of performing the Services under this Agreement (“Process Improvements”). CPL agrees to promptly disclose all Process Improvements to Helix as they occur.
Appears in 3 contracts
Sources: Topical Interferon Alpha 2b GMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement (Helix BioPharma Corp), GMP Process Development and Manufacturing Agreement (Helix BioPharma Corp), Topical Interferon Alpha 2b GMP Process Development, Scale Up and Clinical Supplies Manufacturing Agreement (Helix BioPharma Corp)